Request for Covid-19 Impact Assessment of this Report
The United States Cystic Fibrosis Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cystic Fibrosis Therapeutics market, reaching US$ million by the year 2028. As for the Europe Cystic Fibrosis Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Cystic Fibrosis Therapeutics players cover Vertex Pharmaceuticals, F. Hoffmann-La Roche, AbbVie, and Gilead Sciences, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Cystic Fibrosis Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
CFTR
Mucolytics
PERT
Anti-infectives
Bronchodilators
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Clinics
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Vertex Pharmaceuticals
F. Hoffmann-La Roche
AbbVie
Gilead Sciences
Novartis
AstraZeneca
Bayer
Celtaxsys
Pharmaxis
ProQR Therapeutics
PTC Therapeutics
Alcresta Therapeutics
Insmed Incorporated
Savara
Cyclacel Pharmaceuticals
Vectura
Allergan
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cystic Fibrosis Therapeutics Market Size 2017-2028
2.1.2 Cystic Fibrosis Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Cystic Fibrosis Therapeutics Segment by Type
2.2.1 CFTR
2.2.2 Mucolytics
2.2.3 PERT
2.2.4 Anti-infectives
2.2.5 Bronchodilators
2.3 Cystic Fibrosis Therapeutics Market Size by Type
2.3.1 Cystic Fibrosis Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Cystic Fibrosis Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Cystic Fibrosis Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 Cystic Fibrosis Therapeutics Market Size by Application
2.5.1 Cystic Fibrosis Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Cystic Fibrosis Therapeutics Market Size Market Share by Application (2017-2022)
3 Cystic Fibrosis Therapeutics Market Size by Player
3.1 Cystic Fibrosis Therapeutics Market Size Market Share by Players
3.1.1 Global Cystic Fibrosis Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Cystic Fibrosis Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Cystic Fibrosis Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cystic Fibrosis Therapeutics by Regions
4.1 Cystic Fibrosis Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Cystic Fibrosis Therapeutics Market Size Growth (2017-2022)
4.3 APAC Cystic Fibrosis Therapeutics Market Size Growth (2017-2022)
4.4 Europe Cystic Fibrosis Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Cystic Fibrosis Therapeutics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Cystic Fibrosis Therapeutics Market Size by Country (2017-2022)
5.2 Americas Cystic Fibrosis Therapeutics Market Size by Type (2017-2022)
5.3 Americas Cystic Fibrosis Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cystic Fibrosis Therapeutics Market Size by Region (2017-2022)
6.2 APAC Cystic Fibrosis Therapeutics Market Size by Type (2017-2022)
6.3 APAC Cystic Fibrosis Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cystic Fibrosis Therapeutics by Country (2017-2022)
7.2 Europe Cystic Fibrosis Therapeutics Market Size by Type (2017-2022)
7.3 Europe Cystic Fibrosis Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cystic Fibrosis Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Cystic Fibrosis Therapeutics Market Forecast
10.1 Global Cystic Fibrosis Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Cystic Fibrosis Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Cystic Fibrosis Therapeutics Forecast
10.1.3 APAC Cystic Fibrosis Therapeutics Forecast
10.1.4 Europe Cystic Fibrosis Therapeutics Forecast
10.1.5 Middle East & Africa Cystic Fibrosis Therapeutics Forecast
10.2 Americas Cystic Fibrosis Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Cystic Fibrosis Therapeutics Market Forecast
10.2.2 Canada Cystic Fibrosis Therapeutics Market Forecast
10.2.3 Mexico Cystic Fibrosis Therapeutics Market Forecast
10.2.4 Brazil Cystic Fibrosis Therapeutics Market Forecast
10.3 APAC Cystic Fibrosis Therapeutics Forecast by Region (2023-2028)
10.3.1 China Cystic Fibrosis Therapeutics Market Forecast
10.3.2 Japan Cystic Fibrosis Therapeutics Market Forecast
10.3.3 Korea Cystic Fibrosis Therapeutics Market Forecast
10.3.4 Southeast Asia Cystic Fibrosis Therapeutics Market Forecast
10.3.5 India Cystic Fibrosis Therapeutics Market Forecast
10.3.6 Australia Cystic Fibrosis Therapeutics Market Forecast
10.4 Europe Cystic Fibrosis Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Cystic Fibrosis Therapeutics Market Forecast
10.4.2 France Cystic Fibrosis Therapeutics Market Forecast
10.4.3 UK Cystic Fibrosis Therapeutics Market Forecast
10.4.4 Italy Cystic Fibrosis Therapeutics Market Forecast
10.4.5 Russia Cystic Fibrosis Therapeutics Market Forecast
10.5 Middle East & Africa Cystic Fibrosis Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Cystic Fibrosis Therapeutics Market Forecast
10.5.2 South Africa Cystic Fibrosis Therapeutics Market Forecast
10.5.3 Israel Cystic Fibrosis Therapeutics Market Forecast
10.5.4 Turkey Cystic Fibrosis Therapeutics Market Forecast
10.5.5 GCC Countries Cystic Fibrosis Therapeutics Market Forecast
10.6 Global Cystic Fibrosis Therapeutics Forecast by Type (2023-2028)
10.7 Global Cystic Fibrosis Therapeutics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Vertex Pharmaceuticals
11.1.1 Vertex Pharmaceuticals Company Information
11.1.2 Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Product Offered
11.1.3 Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Vertex Pharmaceuticals Main Business Overview
11.1.5 Vertex Pharmaceuticals Latest Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Information
11.2.2 F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Product Offered
11.2.3 F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 F. Hoffmann-La Roche Main Business Overview
11.2.5 F. Hoffmann-La Roche Latest Developments
11.3 AbbVie
11.3.1 AbbVie Company Information
11.3.2 AbbVie Cystic Fibrosis Therapeutics Product Offered
11.3.3 AbbVie Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 AbbVie Main Business Overview
11.3.5 AbbVie Latest Developments
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Information
11.4.2 Gilead Sciences Cystic Fibrosis Therapeutics Product Offered
11.4.3 Gilead Sciences Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Gilead Sciences Main Business Overview
11.4.5 Gilead Sciences Latest Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Cystic Fibrosis Therapeutics Product Offered
11.5.3 Novartis Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Novartis Main Business Overview
11.5.5 Novartis Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Cystic Fibrosis Therapeutics Product Offered
11.6.3 AstraZeneca Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Bayer
11.7.1 Bayer Company Information
11.7.2 Bayer Cystic Fibrosis Therapeutics Product Offered
11.7.3 Bayer Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Bayer Main Business Overview
11.7.5 Bayer Latest Developments
11.8 Celtaxsys
11.8.1 Celtaxsys Company Information
11.8.2 Celtaxsys Cystic Fibrosis Therapeutics Product Offered
11.8.3 Celtaxsys Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Celtaxsys Main Business Overview
11.8.5 Celtaxsys Latest Developments
11.9 Pharmaxis
11.9.1 Pharmaxis Company Information
11.9.2 Pharmaxis Cystic Fibrosis Therapeutics Product Offered
11.9.3 Pharmaxis Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Pharmaxis Main Business Overview
11.9.5 Pharmaxis Latest Developments
11.10 ProQR Therapeutics
11.10.1 ProQR Therapeutics Company Information
11.10.2 ProQR Therapeutics Cystic Fibrosis Therapeutics Product Offered
11.10.3 ProQR Therapeutics Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 ProQR Therapeutics Main Business Overview
11.10.5 ProQR Therapeutics Latest Developments
11.11 PTC Therapeutics
11.11.1 PTC Therapeutics Company Information
11.11.2 PTC Therapeutics Cystic Fibrosis Therapeutics Product Offered
11.11.3 PTC Therapeutics Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 PTC Therapeutics Main Business Overview
11.11.5 PTC Therapeutics Latest Developments
11.12 Alcresta Therapeutics
11.12.1 Alcresta Therapeutics Company Information
11.12.2 Alcresta Therapeutics Cystic Fibrosis Therapeutics Product Offered
11.12.3 Alcresta Therapeutics Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Alcresta Therapeutics Main Business Overview
11.12.5 Alcresta Therapeutics Latest Developments
11.13 Insmed Incorporated
11.13.1 Insmed Incorporated Company Information
11.13.2 Insmed Incorporated Cystic Fibrosis Therapeutics Product Offered
11.13.3 Insmed Incorporated Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Insmed Incorporated Main Business Overview
11.13.5 Insmed Incorporated Latest Developments
11.14 Savara
11.14.1 Savara Company Information
11.14.2 Savara Cystic Fibrosis Therapeutics Product Offered
11.14.3 Savara Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Savara Main Business Overview
11.14.5 Savara Latest Developments
11.15 Cyclacel Pharmaceuticals
11.15.1 Cyclacel Pharmaceuticals Company Information
11.15.2 Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Product Offered
11.15.3 Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Cyclacel Pharmaceuticals Main Business Overview
11.15.5 Cyclacel Pharmaceuticals Latest Developments
11.16 Vectura
11.16.1 Vectura Company Information
11.16.2 Vectura Cystic Fibrosis Therapeutics Product Offered
11.16.3 Vectura Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Vectura Main Business Overview
11.16.5 Vectura Latest Developments
11.17 Allergan
11.17.1 Allergan Company Information
11.17.2 Allergan Cystic Fibrosis Therapeutics Product Offered
11.17.3 Allergan Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Allergan Main Business Overview
11.17.5 Allergan Latest Developments
12 Research Findings and Conclusion
Table 1. Cystic Fibrosis Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of CFTR
Table 3. Major Players of Mucolytics
Table 4. Major Players of PERT
Table 5. Major Players of Anti-infectives
Table 6. Major Players of Bronchodilators
Table 7. Cystic Fibrosis Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Cystic Fibrosis Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Cystic Fibrosis Therapeutics Market Size Market Share by Type (2017-2022)
Table 10. Cystic Fibrosis Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Cystic Fibrosis Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Cystic Fibrosis Therapeutics Market Size Market Share by Application (2017-2022)
Table 13. Global Cystic Fibrosis Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Cystic Fibrosis Therapeutics Revenue Market Share by Player (2020-2022)
Table 15. Cystic Fibrosis Therapeutics Key Players Head office and Products Offered
Table 16. Cystic Fibrosis Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Cystic Fibrosis Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Cystic Fibrosis Therapeutics Market Size Market Share by Regions (2017-2022)
Table 21. Americas Cystic Fibrosis Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Cystic Fibrosis Therapeutics Market Size Market Share by Country (2017-2022)
Table 23. Americas Cystic Fibrosis Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Cystic Fibrosis Therapeutics Market Size Market Share by Type (2017-2022)
Table 25. Americas Cystic Fibrosis Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Cystic Fibrosis Therapeutics Market Size Market Share by Application (2017-2022)
Table 27. APAC Cystic Fibrosis Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Cystic Fibrosis Therapeutics Market Size Market Share by Region (2017-2022)
Table 29. APAC Cystic Fibrosis Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Cystic Fibrosis Therapeutics Market Size Market Share by Type (2017-2022)
Table 31. APAC Cystic Fibrosis Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Cystic Fibrosis Therapeutics Market Size Market Share by Application (2017-2022)
Table 33. Europe Cystic Fibrosis Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Cystic Fibrosis Therapeutics Market Size Market Share by Country (2017-2022)
Table 35. Europe Cystic Fibrosis Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Cystic Fibrosis Therapeutics Market Size Market Share by Type (2017-2022)
Table 37. Europe Cystic Fibrosis Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Cystic Fibrosis Therapeutics Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Cystic Fibrosis Therapeutics Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Cystic Fibrosis Therapeutics Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Cystic Fibrosis Therapeutics Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Cystic Fibrosis Therapeutics
Table 46. Key Market Challenges & Risks of Cystic Fibrosis Therapeutics
Table 47. Key Industry Trends of Cystic Fibrosis Therapeutics
Table 48. Global Cystic Fibrosis Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Cystic Fibrosis Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Cystic Fibrosis Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Cystic Fibrosis Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Cystic Fibrosis Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Cystic Fibrosis Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 54. Vertex Pharmaceuticals Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors
Table 55. Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Product Offered
Table 56. Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. Vertex Pharmaceuticals Main Business
Table 58. Vertex Pharmaceuticals Latest Developments
Table 59. F. Hoffmann-La Roche Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors
Table 60. F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Product Offered
Table 61. F. Hoffmann-La Roche Main Business
Table 62. F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. F. Hoffmann-La Roche Latest Developments
Table 64. AbbVie Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors
Table 65. AbbVie Cystic Fibrosis Therapeutics Product Offered
Table 66. AbbVie Main Business
Table 67. AbbVie Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. AbbVie Latest Developments
Table 69. Gilead Sciences Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors
Table 70. Gilead Sciences Cystic Fibrosis Therapeutics Product Offered
Table 71. Gilead Sciences Main Business
Table 72. Gilead Sciences Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Gilead Sciences Latest Developments
Table 74. Novartis Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors
Table 75. Novartis Cystic Fibrosis Therapeutics Product Offered
Table 76. Novartis Main Business
Table 77. Novartis Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. Novartis Latest Developments
Table 79. AstraZeneca Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors
Table 80. AstraZeneca Cystic Fibrosis Therapeutics Product Offered
Table 81. AstraZeneca Main Business
Table 82. AstraZeneca Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. AstraZeneca Latest Developments
Table 84. Bayer Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors
Table 85. Bayer Cystic Fibrosis Therapeutics Product Offered
Table 86. Bayer Main Business
Table 87. Bayer Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. Bayer Latest Developments
Table 89. Celtaxsys Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors
Table 90. Celtaxsys Cystic Fibrosis Therapeutics Product Offered
Table 91. Celtaxsys Main Business
Table 92. Celtaxsys Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. Celtaxsys Latest Developments
Table 94. Pharmaxis Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors
Table 95. Pharmaxis Cystic Fibrosis Therapeutics Product Offered
Table 96. Pharmaxis Main Business
Table 97. Pharmaxis Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. Pharmaxis Latest Developments
Table 99. ProQR Therapeutics Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors
Table 100. ProQR Therapeutics Cystic Fibrosis Therapeutics Product Offered
Table 101. ProQR Therapeutics Main Business
Table 102. ProQR Therapeutics Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 103. ProQR Therapeutics Latest Developments
Table 104. PTC Therapeutics Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors
Table 105. PTC Therapeutics Cystic Fibrosis Therapeutics Product Offered
Table 106. PTC Therapeutics Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 107. PTC Therapeutics Main Business
Table 108. PTC Therapeutics Latest Developments
Table 109. Alcresta Therapeutics Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors
Table 110. Alcresta Therapeutics Cystic Fibrosis Therapeutics Product Offered
Table 111. Alcresta Therapeutics Main Business
Table 112. Alcresta Therapeutics Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 113. Alcresta Therapeutics Latest Developments
Table 114. Insmed Incorporated Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors
Table 115. Insmed Incorporated Cystic Fibrosis Therapeutics Product Offered
Table 116. Insmed Incorporated Main Business
Table 117. Insmed Incorporated Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 118. Insmed Incorporated Latest Developments
Table 119. Savara Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors
Table 120. Savara Cystic Fibrosis Therapeutics Product Offered
Table 121. Savara Main Business
Table 122. Savara Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 123. Savara Latest Developments
Table 124. Cyclacel Pharmaceuticals Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors
Table 125. Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Product Offered
Table 126. Cyclacel Pharmaceuticals Main Business
Table 127. Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 128. Cyclacel Pharmaceuticals Latest Developments
Table 129. Vectura Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors
Table 130. Vectura Cystic Fibrosis Therapeutics Product Offered
Table 131. Vectura Main Business
Table 132. Vectura Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 133. Vectura Latest Developments
Table 134. Allergan Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors
Table 135. Allergan Cystic Fibrosis Therapeutics Product Offered
Table 136. Allergan Main Business
Table 137. Allergan Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 138. Allergan Latest Developments
List of Figures
Figure 1. Cystic Fibrosis Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cystic Fibrosis Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Cystic Fibrosis Therapeutics Market Size Market Share by Type in 2021
Figure 7. Cystic Fibrosis Therapeutics in Hospitals
Figure 8. Global Cystic Fibrosis Therapeutics Market: Hospitals (2017-2022) & ($ Millions)
Figure 9. Cystic Fibrosis Therapeutics in Clinics
Figure 10. Global Cystic Fibrosis Therapeutics Market: Clinics (2017-2022) & ($ Millions)
Figure 11. Global Cystic Fibrosis Therapeutics Market Size Market Share by Application in 2021
Figure 12. Global Cystic Fibrosis Therapeutics Revenue Market Share by Player in 2021
Figure 13. Global Cystic Fibrosis Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Cystic Fibrosis Therapeutics Market Size 2017-2022 ($ Millions)
Figure 15. APAC Cystic Fibrosis Therapeutics Market Size 2017-2022 ($ Millions)
Figure 16. Europe Cystic Fibrosis Therapeutics Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Cystic Fibrosis Therapeutics Market Size 2017-2022 ($ Millions)
Figure 18. Americas Cystic Fibrosis Therapeutics Value Market Share by Country in 2021
Figure 19. Americas Cystic Fibrosis Therapeutics Consumption Market Share by Type in 2021
Figure 20. Americas Cystic Fibrosis Therapeutics Market Size Market Share by Application in 2021
Figure 21. United States Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Cystic Fibrosis Therapeutics Market Size Market Share by Region in 2021
Figure 26. APAC Cystic Fibrosis Therapeutics Market Size Market Share by Application in 2021
Figure 27. China Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Cystic Fibrosis Therapeutics Market Size Market Share by Country in 2021
Figure 34. Europe Cystic Fibrosis Therapeutics Market Size Market Share by Type in 2021
Figure 35. Europe Cystic Fibrosis Therapeutics Market Size Market Share by Application in 2021
Figure 36. Germany Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Cystic Fibrosis Therapeutics Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Cystic Fibrosis Therapeutics Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Cystic Fibrosis Therapeutics Market Size Market Share by Application in 2021
Figure 44. Egypt Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 50. APAC Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 51. Europe Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 53. United States Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 54. Canada Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. China Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Japan Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. Korea Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. India Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Australia Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. Germany Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. France Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. UK Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. Italy Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. Russia Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. Spain Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. Israel Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...